These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 2572609)

  • 1. Regression of left ventricular hypertrophy in treated hypertensive patients with dilevalol and metoprolol--a double blind randomized study.
    Glasser SP; Koehn DK; Powell R
    J Clin Pharmacol; 1989 Sep; 29(9):791-7. PubMed ID: 2572609
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of dilevalol, metoprolol and atenolol on left ventricular mass and function in nonelderly and elderly hypertensive patients.
    Frishman WH; Glasser SP; Strom JA; Schoenberger JA; Liebson P; Poland MP
    Am J Cardiol; 1989 Jun; 63(19):69I-74I. PubMed ID: 2567114
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of beta 2 agonism and beta 1 and beta 2 antagonism on adverse effects and plasma lipoproteins: results of a multicenter comparison of dilevalol and metoprolol.
    Materson BJ; Vlachakis ND; Glasser SP; Lucas C; Ramanathan KB; Ahmad S; Morledge JH; Saunders E; Lutz LJ; Schnaper HW
    Am J Cardiol; 1989 Jun; 63(19):58I-63I. PubMed ID: 2567113
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A multicenter double-blind study of the efficacy and safety of once and twice daily dilevalol compared to propranolol.
    Schoenberger JA; Wallin JD; Gorwit JI; Davidov ME; Michelson EL; Poland MP; Frishman WH
    Am J Hypertens; 1989 Nov; 2(11 Pt 1):840-6. PubMed ID: 2686711
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of labetalol on left ventricular mass and function in hypertension--an assessment by serial echocardiography.
    Kaul U; Mohan JC; Bhatia ML
    Int J Cardiol; 1984 Apr; 5(4):461-73. PubMed ID: 6233228
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Left ventricular hypertrophy regression in hypertensive patients treated with metoprolol.
    Corea L; Bentivoglio M; Verdecchia P; Provvidenza M; Motolese M
    Int J Clin Pharmacol Ther Toxicol; 1984 Jul; 22(7):365-70. PubMed ID: 6236155
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effects of dilevalol, metoprolol, and placebo on ventilatory function in asthmatics.
    Chodosh S; Tuck J; Blasucci DJ
    J Cardiovasc Pharmacol; 1988; 11 Suppl 2():S18-24. PubMed ID: 2464094
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regression of left ventricular mass is accompanied by improvement in rapid left ventricular filling following antihypertensive therapy with metoprolol.
    White WB; Schulman P; Karimeddini MK; Smith VE
    Am Heart J; 1989 Jan; 117(1):145-50. PubMed ID: 2521417
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Renal function effects of dilevalol, a nonselective beta-adrenergic blocking drug with beta-2 agonist activity.
    Cook ME; Wallin JD; Clifton GG; Poland M
    Clin Pharmacol Ther; 1988 Apr; 43(4):393-9. PubMed ID: 3356083
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regression of left ventricular hypertrophy during long-term antihypertensive treatment--a comparison between felodipine and the combination of felodipine and metoprolol.
    Wetzchewald D; Klaus D; Garanin G; Lohr E; Hoffmann J
    J Intern Med; 1992 Mar; 231(3):303-8. PubMed ID: 1532616
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment and post-treatment effects of alpha- versus beta-receptor blockers on left ventricular structure and function in essential hypertension.
    Schobel HP; Langenfeld M; Gatzka C; Schmieder RE
    Am Heart J; 1996 Nov; 132(5):1004-9. PubMed ID: 8892775
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Left ventricular hypertrophy reversal with labetalol and propranolol: a prospective randomized, double-blind study.
    Szlachcic J; Hall WD; Tubau JF; Porter V; Vollmer C; Wollam G; Hirsch A; Massie B
    Cardiovasc Drugs Ther; 1990 Apr; 4(2):427-33. PubMed ID: 2149513
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Regression of myocardial hypertrophy in hypertensives on chronic beta-receptor block].
    Franz IW; Wiewel D; Behr M; Ketelhut R
    Dtsch Med Wochenschr; 1986 Apr; 111(14):530-4. PubMed ID: 2869930
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dilevalol: a selective beta-2 adrenergic agonist vasodilator with beta adrenergic blocking activity.
    Wallin JD; Frishman WH
    J Clin Pharmacol; 1989 Dec; 29(12):1057-68. PubMed ID: 2693499
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multicenter comparison of dilevalol to placebo in patients with mild hypertension.
    Frishman WH; Schoenberger JA; Gorwit JI; Bedsole GD; Cubbon J; Poland MP
    Am J Hypertens; 1988 Jul; 1(3 Pt 3):295S-299S. PubMed ID: 3046631
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dilevalol compared with propranolol and placebo for systemic hypertension.
    Schoenberger JA; Frishman WH; Wallin JD; Gorwit J; Davidov ME; Michelson EL; Bedsole GD; Cubbon J; Poland MP
    Am J Cardiol; 1989 Jun; 63(19):45I-49I. PubMed ID: 2658529
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Blood pressure lowering efficacy of dual alpha and beta blockers for primary hypertension.
    Wong GW; Laugerotte A; Wright JM
    Cochrane Database Syst Rev; 2015 Aug; 2015(8):CD007449. PubMed ID: 26306578
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multiclinic comparison of labetalol to metoprolol in treatment of mild to moderate systemic hypertension.
    Frishman WH; Michelson EL; Johnson BF; Poland MP
    Am J Med; 1983 Oct; 75(4A):54-67. PubMed ID: 6356900
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antifibrillatory efficacy of concomitant beta adrenergic receptor blockade with dilevalol, the R,R-isomer of labetalol, and muscarinic receptor blockade with methylscopolamine.
    Lynch JJ; Nelson SD; MacEwen SA; Driscoll EM; Lucchesi BR
    J Pharmacol Exp Ther; 1987 May; 241(2):741-9. PubMed ID: 2883307
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of weight reduction on left ventricular mass. A randomized controlled trial in young, overweight hypertensive patients.
    MacMahon SW; Wilcken DE; Macdonald GJ
    N Engl J Med; 1986 Feb; 314(6):334-9. PubMed ID: 2935737
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.